- Home
- OBE vs NPCE Comparison
OBE vs NPCE Comparison
Compare OBE & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBE | NPCE |
|---|---|---|
| Founded | 1979 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.9M | 485.6M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OBE | NPCE |
|---|---|---|
| Price | $8.50 | $14.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $10.00 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 533.5K | 182.2K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | N/A | $25.95 |
| Revenue Next Year | $20.21 | $0.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $3.88 | $7.56 |
| 52 Week High | $8.85 | $18.97 |
Technical Indicators
Market Signals| Indicator | OBE | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 64.74 | 41.96 |
| Support Level | $5.57 | $14.02 |
| Resistance Level | N/A | $16.96 |
| Average True Range (ATR) | 0.41 | 0.82 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 79.31 | 48.89 |
Price Performance
Historical ComparisonAbout OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Sale of Oil.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.